PTGS2 and lung cancer: However, several studies have shown that overexpression of COX-2, which is inhibited by aspirin, is associated with poor prognosis in lung cancer (Achiwa et al, 1999; Khuri et al, 2001), suggesting that if aspirin has an effect on survival in lung cancer, it is more likely to be beneficial than detrimental.